Pakistan approves AstraZeneca, SinoPharm Covid-19 vaccines for emergency use
APP/Islamabad
(Reuters)
Earlier both vaccines were evaluated for their safety and quality.
Pakistan s Drug Regulatory Authority of Pakistan (DRAP) on Monday granted emergency use authorization (EUA) to two different vaccines to protect against Covid-19 in the country after evaluation.
According to spokesperson of DRAP, two Covid vaccines have been granted EUA with certain conditions. Earlier both vaccines were evaluated for their safety and quality.
On January 15, 2021 a vaccine manufactured by AstraZeneca was given EUA. In a meeting conducted by Registration Board of DRAP on Monday, another vaccine manufactured by China National Pharmaceutical Group (SinoPharm) has also been given EUA.